Interventional electrophysiology has made remarkable advancements in the last decade.
Wilmington, Delaware, United States, Transparency Market Research Inc. – Interventional electrophysiology has made remarkable advancements in the last decade. Cardiac mapping is one of the highly advanced processes associated with the collection and display of data gathered from an electrocardiogram. It is characterized as a process involving the identification of spatial and temporal distribution of myocardial electrical signals during a particular heart rhythm.
Read Report Overview - https://www.transparencymarketresearch.com/cardiac-mapping-systems-market.html
The information collected is transmitted to the software, where a 3-dimentional (3D) model of the heart is created, showing the electric waves generated during each heartbeat. The technique shows the location and movement of the catheter inside the heart. The simple procedure of cardiac mapping allows physicians to accurately pinpoint the location of heart chambers that are experiencing arrhythmia.
Introduction of numerous advanced diagnostic technologies by medical device companies, rise in demand for the precise diagnosis of critical cardiac diseases, and availability of well-qualified interventional cardiologists in developed economies are expected to augment the expansion of the cardiac mapping systems market during the forecast period. However, lack of awareness about cardiac mapping systems in developing countries, their high cost, and the criticalities associated with the procedure of cardiac mapping are projected to be major restraints of the cardiac mapping systems market in the near future.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46353
The global cardiac mapping systems market can be segmented based on technology, end-user, and region. Based on technology, the global cardiac mapping systems market can be categorized into contact mapping systems and non-contact mapping systems. The contact mapping systems segment accounted for a prominent market share in terms of revenue in 2017 and is expected to continue to remain dominant throughout the forecast period.
Rise in incidence of cardiovascular diseases among all age groups owing to a sedentary lifestyle and rise in obesity and the involvement of key companies, such as Abbott and Medtronic, in the manufacture of contact mapping systems are estimated to augment the expansion of contact mapping systems market during the forecast period. Introduction of cardiac mapping systems without catheters by companies such as Medtronic, specifically for ventricular tachycardia (VT) and supraventricular tachycardia (SVTs), are projected to fuel the non-contact mapping systems segment in the coming years.
Request for ToC – https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=46353
In terms of end-user, the global cardiac mapping systems market can be categorized into hospitals, ambulatory surgical centers, clinics, and others. Rise in investment by public and private players in multispecialty hospitals with an aim to improve health care infrastructure and increase in adoption for advanced and precise diagnostic tools by interventional cardiologists in hospitals were key factors for the dominance of the hospitals segment in global cardiac mapping systems market in terms of revenue in 2017.
The segment is expected to maintain its leading position throughout the forecast period due to significant prevalence of cardiac arrhythmias and rise in awareness about them in emerging countries. However, the clinics segment is estimated to expand at a comparatively higher CAGR between 2018 and 2026, owing to a rise in demand by patients for cost-effective diagnosis and treatment for cardiovascular diseases and improved reimbursement policies across the globe.
In terms of region, the global cardiac mapping systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a prominent market share in 2017, which is attributed to the flexible management of patients in U.S. hospitals and favorable reimbursement policies for cardiovascular diseases. The region is expected to remain dominant throughout the forecast period, due to the integration of technology with health care in health care facilities in North America.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=46353
Europe is estimated to constitute key market share during the forecast period. Rise in the number of interventional cardiologists in India and Australia is increasing awareness about cardiac mapping systems in those countries. This is considered to be a key factor for the estimated expansion of the market in Asia Pacific at a relatively significant CAGR during the forecast period.
Major players operating in the global cardiac mapping systems market include Abbott, Medtronic, Biosense Webster, Inc., Boston Scientific Corporation, Kardium, Inc., Lepu Medical, Catheter Robotics, Inc., and EP Solutions SA.
More Trending Reports by Transparency Market Research –
Disposable Syringes Market: The disposable syringes market is expected to progress at a robust CAGR of ~7% during the forecast period.
Veterinary Endoscopes Market: The global veterinary endoscopes market was valued at US$ 458.3 Mn in 2018 and is anticipated to expand at a CAGR of 7.1% from 2019 to 2027
Medical Foods Market: The medical foods market is slated to progress at a robust CAGR of ~6% during the forecast period.
Surgical Retractors Market: The global surgical retractors market is expected to reach ~US$ 3.1 Bn by the end of 2030.
Dental Consumables Market: The global dental Consumables market was valued at US$ 23,718.0 Mn in 2018 and is anticipated to expand at a CAGR of 5.4% from 2019 to 2027.
Vascular Stents Market: The global vascular stents market is expected to grow at a moderate CAGR of ~5% during the forecast period.
Monopolar Electrosurgery Market: The global monopolar electrosurgery market was valued at US$ 1.72 Bn in 2018 and is anticipated to expand at a CAGR of 3.9% from 2019 to 2027
Vertebroplasty and Kyphoplasty Market: The global vertebroplasty and kyphoplasty market was valued at US$ 1.0 Bn in 2018 and is anticipated to expand at a CAGR of 4.6% from 2019 to 2027.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com